109 research outputs found

    Prvi dokaz invazije pasa lutalica na Filipinima protozoonom Babesia gibsoni pomoću imunokromatografskog testa.

    Get PDF
    A total of 46 stray dogs in an impounding facility comprising 17 males and 29 females were diagnosed using the Babesia gibsoni P50 truncated antigen immunochromatographic test (P50t-ICT). Thirteen dogs (28.0%) were serologically positive. There was no cross-reactivity with serum samples from Babesia canis (= B. vogeli)-infected dogs and none of the ICT strips showed invalid results, which reinforce the sensitivity and specificity of the P50t antigen and the reliability and accuracy of the P50t-ICT. Thirty-seven (80.4%) dogs had mixed tick infestations principally of the genus Rhipicephalus and Boophilus. From 11 seropositive and 20 seronegative dogs a total of 80 Rhipicephalus ticks were pooled. Among the 33 seronegative dogs, 48.5% had infestation with Rhipicephalus sp. only, 12.1% with Boophilus sp. only, 12.1% with mixed Rhipicephalus sp. and Boophilus sp., and 19.6% were un-infested. This paper documents the first account of serological detection of B. gibsoni in stray dogs and their infestation mainly with Rhipicephalus sp. suggestive of their role as putative key vectors of B. gibsoni in Philippine stray dogs.Istraživanje je provedeno kako bi se imunokromatografskim testom (P50t-ICT) dokazala prisutnost protozoona Babesia gibsoni u pasa lutalica na Filipinima. Ukupno je bilo pretraženo 46 pasa, 17 mužjaka i 29 ženki, na prisutnost antigena p50 protozoona Babesia gibsoni. Trinaest pasa (28%) bilo je serološki pozitivno. Nije ustanovljen nijedan slučaj križne reaktivnosti s uzorcima seruma pasa prirodno invadiranima protozoonom Babesia canis (Babesia vogeli). Test se pokazao prikladnim, osjetljivim, specifičnim, pouzdanim i točnim. U 37 pasa (80,4%) dokazane su mješovite infestacije krpeljima rodova Rhipicephalus i Boophilus. Na 11 serološki pozitivnih i 20 serološki negativnih pasa pronađeno je ukupno 80 krpelja iz roda Rhipicephalus. Od 33 serološki negativna psa krpelji roda Rhipicephalus dokazani su u 48,5%, roda Boophilus u 12,1%, a jedna mješovita infestacija vrstama tih rodova dokazana je također u 12,1% pasa. U 27,3% pasa krpelji nisu dokazani. Ovaj rad prvi put prikazuje mogućnost serološkoga dokaza infekcije vrstom B. gibsoni u pasa lutalica i njihovu infestaciju pretežito krpeljima roda Rhipicephalus kao ključnih prijenosnika B. gibsoni u pasa lutalica na Filipinim

    Prvi dokaz invazije pasa lutalica na Filipinima protozoonom Babesia gibsoni pomoću imunokromatografskog testa.

    Get PDF
    A total of 46 stray dogs in an impounding facility comprising 17 males and 29 females were diagnosed using the Babesia gibsoni P50 truncated antigen immunochromatographic test (P50t-ICT). Thirteen dogs (28.0%) were serologically positive. There was no cross-reactivity with serum samples from Babesia canis (= B. vogeli)-infected dogs and none of the ICT strips showed invalid results, which reinforce the sensitivity and specificity of the P50t antigen and the reliability and accuracy of the P50t-ICT. Thirty-seven (80.4%) dogs had mixed tick infestations principally of the genus Rhipicephalus and Boophilus. From 11 seropositive and 20 seronegative dogs a total of 80 Rhipicephalus ticks were pooled. Among the 33 seronegative dogs, 48.5% had infestation with Rhipicephalus sp. only, 12.1% with Boophilus sp. only, 12.1% with mixed Rhipicephalus sp. and Boophilus sp., and 19.6% were un-infested. This paper documents the first account of serological detection of B. gibsoni in stray dogs and their infestation mainly with Rhipicephalus sp. suggestive of their role as putative key vectors of B. gibsoni in Philippine stray dogs.Istraživanje je provedeno kako bi se imunokromatografskim testom (P50t-ICT) dokazala prisutnost protozoona Babesia gibsoni u pasa lutalica na Filipinima. Ukupno je bilo pretraženo 46 pasa, 17 mužjaka i 29 ženki, na prisutnost antigena p50 protozoona Babesia gibsoni. Trinaest pasa (28%) bilo je serološki pozitivno. Nije ustanovljen nijedan slučaj križne reaktivnosti s uzorcima seruma pasa prirodno invadiranima protozoonom Babesia canis (Babesia vogeli). Test se pokazao prikladnim, osjetljivim, specifičnim, pouzdanim i točnim. U 37 pasa (80,4%) dokazane su mješovite infestacije krpeljima rodova Rhipicephalus i Boophilus. Na 11 serološki pozitivnih i 20 serološki negativnih pasa pronađeno je ukupno 80 krpelja iz roda Rhipicephalus. Od 33 serološki negativna psa krpelji roda Rhipicephalus dokazani su u 48,5%, roda Boophilus u 12,1%, a jedna mješovita infestacija vrstama tih rodova dokazana je također u 12,1% pasa. U 27,3% pasa krpelji nisu dokazani. Ovaj rad prvi put prikazuje mogućnost serološkoga dokaza infekcije vrstom B. gibsoni u pasa lutalica i njihovu infestaciju pretežito krpeljima roda Rhipicephalus kao ključnih prijenosnika B. gibsoni u pasa lutalica na Filipinim

    Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

    Get PDF
    BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

    Geographic patterns of tree dispersal modes in Amazonia and their ecological correlates

    Get PDF
    Aim: To investigate the geographic patterns and ecological correlates in the geographic distribution of the most common tree dispersal modes in Amazonia (endozoochory, synzoochory, anemochory and hydrochory). We examined if the proportional abundance of these dispersal modes could be explained by the availability of dispersal agents (disperser-availability hypothesis) and/or the availability of resources for constructing zoochorous fruits (resource-availability hypothesis). Time period: Tree-inventory plots established between 1934 and 2019. Major taxa studied: Trees with a diameter at breast height (DBH) ≥ 9.55 cm. Location: Amazonia, here defined as the lowland rain forests of the Amazon River basin and the Guiana Shield. Methods: We assigned dispersal modes to a total of 5433 species and morphospecies within 1877 tree-inventory plots across terra-firme, seasonally flooded, and permanently flooded forests. We investigated geographic patterns in the proportional abundance of dispersal modes. We performed an abundance-weighted mean pairwise distance (MPD) test and fit generalized linear models (GLMs) to explain the geographic distribution of dispersal modes. Results: Anemochory was significantly, positively associated with mean annual wind speed, and hydrochory was significantly higher in flooded forests. Dispersal modes did not consistently show significant associations with the availability of resources for constructing zoochorous fruits. A lower dissimilarity in dispersal modes, resulting from a higher dominance of endozoochory, occurred in terra-firme forests (excluding podzols) compared to flooded forests. Main conclusions: The disperser-availability hypothesis was well supported for abiotic dispersal modes (anemochory and hydrochory). The availability of resources for constructing zoochorous fruits seems an unlikely explanation for the distribution of dispersal modes in Amazonia. The association between frugivores and the proportional abundance of zoochory requires further research, as tree recruitment not only depends on dispersal vectors but also on conditions that favour or limit seedling recruitment across forest types

    Mapping density, diversity and species-richness of the Amazon tree flora

    Get PDF
    Using 2.046 botanically-inventoried tree plots across the largest tropical forest on Earth, we mapped tree species-diversity and tree species-richness at 0.1-degree resolution, and investigated drivers for diversity and richness. Using only location, stratified by forest type, as predictor, our spatial model, to the best of our knowledge, provides the most accurate map of tree diversity in Amazonia to date, explaining approximately 70% of the tree diversity and species-richness. Large soil-forest combinations determine a significant percentage of the variation in tree species-richness and tree alpha-diversity in Amazonian forest-plots. We suggest that the size and fragmentation of these systems drive their large-scale diversity patterns and hence local diversity. A model not using location but cumulative water deficit, tree density, and temperature seasonality explains 47% of the tree species-richness in the terra-firme forest in Amazonia. Over large areas across Amazonia, residuals of this relationship are small and poorly spatially structured, suggesting that much of the residual variation may be local. The Guyana Shield area has consistently negative residuals, showing that this area has lower tree species-richness than expected by our models. We provide extensive plot meta-data, including tree density, tree alpha-diversity and tree species-richness results and gridded maps at 0.1-degree resolution

    7th Drug hypersensitivity meeting: part two

    Get PDF
    No abstract availabl

    Consistent patterns of common species across tropical tree communities

    Get PDF
    Trees structure the Earth’s most biodiverse ecosystem, tropical forests. The vast number of tree species presents a formidable challenge to understanding these forests, including their response to environmental change, as very little is known about most tropical tree species. A focus on the common species may circumvent this challenge. Here we investigate abundance patterns of common tree species using inventory data on 1,003,805 trees with trunk diameters of at least 10 cm across 1,568 locations1,2,3,4,5,6 in closed-canopy, structurally intact old-growth tropical forests in Africa, Amazonia and Southeast Asia. We estimate that 2.2%, 2.2% and 2.3% of species comprise 50% of the tropical trees in these regions, respectively. Extrapolating across all closed-canopy tropical forests, we estimate that just 1,053 species comprise half of Earth’s 800 billion tropical trees with trunk diameters of at least 10 cm. Despite differing biogeographic, climatic and anthropogenic histories7, we find notably consistent patterns of common species and species abundance distributions across the continents. This suggests that fundamental mechanisms of tree community assembly may apply to all tropical forests. Resampling analyses show that the most common species are likely to belong to a manageable list of known species, enabling targeted efforts to understand their ecology. Although they do not detract from the importance of rare species, our results open new opportunities to understand the world’s most diverse forests, including modelling their response to environmental change, by focusing on the common species that constitute the majority of their trees.Publisher PDFPeer reviewe

    Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

    Get PDF
    Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication

    Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

    Get PDF
    BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years
    corecore